Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.69% |
| 2 | Technology | 12.68% |
| 3 | Financials | 12.18% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KA
2326
DELISTED
Kineta, Inc. Common Stock
KA
| $1.56M | ﹤0.01% |
+3,451
| New | +$2.34M |
|
|
ARE.PRD
2327
DELISTED
Alexandria Real Estate Equities Inc 7.00% Series D Preferred Stock
ARE.PRD
| $1.56M | ﹤0.01% |
46,627
| – | – |
|
|
CARM
2328
DELISTED
Carisma Therapeutics
CARM
| $1.56M | ﹤0.01% |
54,995
+13,493
| +33% | +$430K |
|
2329
iShares Russell 2000 Growth ETF
IWO
$14.1B
| $1.56M | ﹤0.01% |
9,300
-2,931
| -24% | -$547K |
|
|
GES
2330
DELISTED
Guess Inc
GES
| $1.56M | ﹤0.01% |
75,148
-60,569
| -45% | -$1.28M |
|
2331
FNB Corp
FNB
$6.76B
| $1.55M | ﹤0.01% |
157,784
+66,492
| +73% | +$771K |
|
2332
Omnicell
OMCL
$1.88B
| $1.55M | ﹤0.01% |
+25,354
| New | +$1.72M |
|
2333
1-800-Flowers.com
FLWS
$252M
| $1.55M | ﹤0.01% |
+126,749
| New | +$1.52M |
|
2334
ICF International
ICFI
$1.5B
| $1.55M | ﹤0.01% |
23,907
-2,127
| -8% | -$149K |
|
2335
CALL
Danaher
DHR
$138B
| $1.55M | ﹤0.01% |
+16,920
| New | +$1.54M |
|
2336
TAL Education Group
TAL
$6.04B
| $1.55M | ﹤0.01% |
57,973
-375,321
| -87% | -$9.96M |
|
2337
Quaker Houghton
KWR
$2.58B
| $1.54M | ﹤0.01% |
8,687
+4,727
| +119% | +$911K |
|
2338
Liberty Global Class A
LBTYA
$3.59B
| $1.54M | ﹤0.01% |
72,340
-249,045
| -77% | -$6.11M |
|
2339
Ball Corp
BALL
$17.5B
| $1.54M | ﹤0.01% |
33,457
-996,006
| -97% | -$46.5M |
|
2340
Noodles & Co
NDLS
$95.1M
| $1.54M | ﹤0.01% |
27,477
+8,067
| +42% | +$600K |
|
2341
iShares Russell 3000 ETF
IWV
$19.2B
| $1.53M | ﹤0.01% |
10,435
+7,223
| +225% | +$1.15M |
|
|
HMSY
2342
DELISTED
HMS Holdings Corp.
HMSY
| $1.53M | ﹤0.01% |
54,499
-6,571
| -11% | -$213K |
|
2343
American Vanguard Corp
AVD
$68.7M
| $1.53M | ﹤0.01% |
+100,550
| New | +$1.66M |
|
2344
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
| $1.53M | ﹤0.01% |
33,503
-20,017
| -37% | -$961K |
|
|
VSI
2345
DELISTED
Vitamin Shoppe Inc.
VSI
| $1.53M | ﹤0.01% |
321,842
-556,386
| -63% | -$4.18M |
|
|
SPPI
2346
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.52M | ﹤0.01% |
174,058
+120,541
| +225% | +$1.54M |
|
|
DSPG
2347
DELISTED
DSP Group Inc
DSPG
| $1.52M | ﹤0.01% |
135,982
-213,743
| -61% | -$2.5M |
|
2348
TriCo Bancshares
TCBK
$1.85B
| $1.52M | ﹤0.01% |
+45,039
| New | +$1.62M |
|
|
OXFD
2349
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.51M | ﹤0.01% |
117,914
+63,617
| +117% | +$965K |
|
|
HIVE
2350
DELISTED
Aerohive Networks
HIVE
| $1.5M | ﹤0.01% |
461,526
-83,679
| -15% | -$315K |
|
Similar funds
Millennium Management's Q4 2018 Portfolio in Review
As of Q4 2018, Millennium Management held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Millennium Management withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Athenahealth, Inc. worth $135M.
- Millennium Management's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Millennium Management added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Millennium Management's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Millennium Management fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Millennium Management's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Millennium Management opened 702 new positions and closed 844 in Q4 2018.
- Millennium Management's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.